This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents. Top assignees: Addex Pharma, S.a., Janssen Pharmaceutica Nv, Janssen Pharmaceuticals, Inc.. Active years: 2012-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Vosselaar, BE (2012)
- Beerse, BE (2014 - 2016)
Company Filing History:
2 out of 37 
2 out of 2,101 
2 out of 161 Years Active: 2012-2016
Certainly! Here is an article about inventor Frank Matthias Dautzenberg:
Title: Innovator Spotlight: Frank Matthias Dautzenberg, Pioneering Research in Neurological and Psychiatric Disorders
Introduction:
Frank Matthias Dautzenberg is a distinguished inventor hailing from Beerse, Belgium, with an impressive portfolio of 4 patents in the field of pharmaceuticals and neurology. His groundbreaking work revolves around innovative compounds aimed at treating neurological and psychiatric disorders, particularly those associated with glutamate dysfunction.
Latest Patents:
Dautzenberg's latest patents revolve around 1, 4-disubstituted 3-cyano-pyridone derivatives as positive allosteric modulators of MGLUR2-receptors. These compounds, as per Formula (I), are designed to target the metabotropic receptors-subtype 2 (“mGluR2”), with applications in treating conditions like anxiety, schizophrenia, migraine, depression, and epilepsy. The pharmaceutical compositions derived from these compounds hold promising potential for the prevention and treatment of diseases involving mGluR2.
Career Highlights:
Throughout his career, Dautzenberg has made significant contributions to the pharmaceutical industry. He has been associated with renowned companies such as Janssen Pharmaceutica Nv and Janssen Pharmaceuticals, Inc., where his innovative research has fueled advancements in drug development and therapeutic interventions for complex disorders.
Collaborations:
Dautzenberg has collaborated closely with esteemed professionals in the field, including Julen Oyarzabal Santamarina and José Ignacio Andrés-Gil. These collaborations have led to synergistic efforts in pushing the boundaries of pharmaceutical research and developing novel solutions for challenging medical conditions.
Conclusion:
Frank Matthias Dautzenberg's dedication to scientific innovation and his relentless pursuit of novel treatments for neurological and psychiatric disorders have established him as a visionary in the field of pharmaceutical research. His patents stand as a testament to his unwavering commitment to advancing healthcare through cutting-edge discoveries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile